{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:01:08Z","timestamp":1785423668691,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jaci.2015.10.026","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T20:30:58Z","timestamp":1450297858000},"page":"1148-1153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Consequences of avoiding \u03b2-lactams in patients with \u03b2-lactam allergies"],"prefix":"10.1016","volume":"137","author":[{"given":"Meghan N.","family":"Jeffres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna P.","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrica E.","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett E.","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2015.10.026_bib1","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/archinte.160.18.2819","article-title":"The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance","volume":"160","author":"Lee","year":"2000","journal-title":"Arch Intern Med"},{"issue":"62","key":"10.1016\/j.jaci.2015.10.026_bib2","first-page":"1","article-title":"Inpatient care for septicemia or sepsis: a challenge for patients and hospitals","author":"Hall","year":"2011","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jaci.2015.10.026_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaci.2015.10.026_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2015.10.026_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2015.10.026_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and\u00a0healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2015.10.026_bib7","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012\u00a0Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2015.10.026_bib8","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2015.10.026_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2015.10.026_bib10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","article-title":"Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department","volume":"38","author":"Gaieski","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaci.2015.10.026_bib11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of\u00a0hypotension before initiation of effective antimicrobial therapy is the critical\u00a0determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaci.2015.10.026_bib12","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential\u00a0risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaci.2015.10.026_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000318844","article-title":"Tolerability of aztreonam in patients with cell-mediated allergy to \u03b2-lactams","volume":"155","author":"Buonomo","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2015.10.026_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/039463200802100215","article-title":"Tolerability of aztreonam in patients with IgE-mediated hypersensitivity to beta-lactams","volume":"21","author":"Patriarca","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaci.2015.10.026_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.diagmicrobio.2006.07.009","article-title":"Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)","volume":"57","author":"Rhomberg","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jaci.2015.10.026_bib16","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1097\/01.CCM.0000098031.24329.10","article-title":"Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis","volume":"31","author":"Garnacho-Montero","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaci.2015.10.026_bib17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaci.2015.10.026_bib18","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1097\/CCM.0b013e318250aa72","article-title":"The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*","volume":"40","author":"Labelle","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaci.2015.10.026_bib19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaci.2015.10.026_bib20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/jac\/44.6.799","article-title":"Levofloxacin in the empirical treatment of patients with suspected bacteraemia\/sepsis: comparison with imipenem\/cilastatin in an open, randomized trial","volume":"44","author":"Geddes","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaci.2015.10.026_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1086\/648720","article-title":"Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials","volume":"50","author":"Gardiner","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2015.10.026_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0149-2918(03)80091-7","article-title":"Levofloxacin compared with imipenem\/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study","volume":"25","author":"West","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaci.2015.10.026_bib23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/thorax.55.12.1033","article-title":"Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem\/cilastatin","volume":"55","author":"Torres","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2015.10.026_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.diagmicrobio.2010.05.012","article-title":"Comparison of tigecycline with imipenem\/cilastatin for the treatment of hospital-acquired pneumonia","volume":"68","author":"Freire","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jaci.2015.10.026_bib25","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1469-0691.2010.03122.x","article-title":"A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections","volume":"16","author":"Towfigh","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaci.2015.10.026_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1471-2334-10-217","article-title":"Efficacy and safety of tigecycline monotherapy vs. imipenem\/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial","volume":"10","author":"Chen","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaci.2015.10.026_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/01.sla.0000230024.84190.a8","article-title":"Randomized controlled\u00a0trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections","volume":"244","author":"Malangoni","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.jaci.2015.10.026_bib28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.10.026_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaip.2013.01.006","article-title":"Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital","volume":"1","author":"Picard","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2015.10.026_bib30","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jclinpath-2014-202438","article-title":"A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of 'penicillin allergy' in a UK teaching hospital","volume":"67","author":"Li","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2015.10.026_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaci.2010.08.025","article-title":"The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge","volume":"127","author":"Caubet","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.10.026_bib32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.otohns.2006.10.007","article-title":"Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis","volume":"136","author":"Pichichero","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2015.10.026_bib33","doi-asserted-by":"crossref","first-page":"354.e11","DOI":"10.1016\/j.amjmed.2005.10.052","article-title":"Is there cross-reactivity between penicillins and cephalosporins?","volume":"119","author":"Apter","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2015.10.026_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7326\/0003-4819-141-1-200407060-00010","article-title":"Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins","volume":"141","author":"Romano","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2015.10.026_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2009.02.031","article-title":"Tolerability of imipenem in children with IgE-mediated hypersensitivity to penicillins","volume":"124","author":"Atanaskovic-Markovic","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.10.026_bib36","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/cid\/ciu587","article-title":"A systematic review: can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins?","volume":"59","author":"Kula","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2015.10.026_bib37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.10.029","article-title":"Case fatality and population mortality associated with anaphylaxis in the United States","volume":"133","author":"Ma","year":"2014","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915015845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915015845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:58:30Z","timestamp":1758790710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674915015845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0091674915015845"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2015.10.026","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consequences of avoiding \u03b2-lactams in patients with \u03b2-lactam allergies","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2015.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}